SLAMF8 and cancer: Given the consequences of elevated type I IFN secretion in various disorders, the involvement of SLAMF7 and SLAMF8 extends beyond infectious diseases to cancer and autoimmunity (9, 21, 37, 43, 59, 60, 62, 66).